Freiburg, Germany

Julian Aranda-Martinez

This inventor holds 1 USPTO granted patent. Top assignee: Pfizer Corporation. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julian Aranda-Martinez. Retrieved from https://idiyas.com/inventor/julian-aranda-martinez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Julian Aranda-Martinez

Introduction

Julian Aranda-Martinez is a notable inventor based in Freiburg, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for drug preparation. His work is recognized for its impact on improving medication efficacy and safety.

Latest Patents

Julian holds a patent for an improved process for the preparation of a polymorph of eletriptan hemisulphate. This innovation is crucial in enhancing the therapeutic properties of the drug, which is used in the treatment of migraines. His patent portfolio includes 1 patent that showcases his expertise in pharmaceutical processes.

Career Highlights

Julian is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His role involves research and development, where he applies his knowledge to create innovative solutions in drug formulation. His contributions have been instrumental in advancing the company's product offerings.

Collaborations

Throughout his career, Julian has collaborated with esteemed colleagues such as Juergen Friedrich Kleinschroth and Julie Ann MacRae. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Julian Aranda-Martinez exemplifies the spirit of innovation in the pharmaceutical industry. His work not only contributes to the advancement of medical science but also improves the lives of patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…